1
|
Marron JM, Hantel A, Abel GA, Peppercorn JM. Ethics Consultation in Oncology: The Search for Quality in Quantity. JCO Oncol Pract 2022; 18:610-613. [PMID: 35947815 PMCID: PMC9509056 DOI: 10.1200/op.22.00440] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2022] [Accepted: 07/11/2022] [Indexed: 09/03/2023] Open
Affiliation(s)
- Jonathan M. Marron
- Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
- Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA
- Center for Bioethics, Harvard Medical School, Boston, MA
- Office of Ethics, Boston Children's Hospital, Boston, MA
| | - Andrew Hantel
- Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA
- Center for Bioethics, Harvard Medical School, Boston, MA
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
| | - Gregory A. Abel
- Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA
- Center for Bioethics, Harvard Medical School, Boston, MA
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
| | - Jeffrey M. Peppercorn
- Center for Bioethics, Harvard Medical School, Boston, MA
- Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
| |
Collapse
|
2
|
Hajjaji N, Lepoutre K, Lakhdar S, Bécourt S, Bellier C, Kaczmarek E, Broyelle A, Giscard S, Lartigau E. 16 Months Follow Up of Patients’ Behavior and Mild COVID-19 Patterns in a Large Cohort of Cancer Patients During the Pandemic. Front Oncol 2022; 12:901426. [PMID: 35747798 PMCID: PMC9209649 DOI: 10.3389/fonc.2022.901426] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2022] [Accepted: 05/16/2022] [Indexed: 11/13/2022] Open
Abstract
Background: Acute severe forms of COVID-19 infection are more likely in cancer patients and growing attention has been given to the persistent symptoms of the disease after severe COVID-19. However, mild illness is the dominant clinical presentation of COVID-19 infection. To investigate patients’ behavior and the short- and longer-term pattern of the disease in cancer patients with mild COVID infection, a longitudinal online survey was conducted for 16 months during the pandemic in a large cohort of cancer patients from a French COVID-19 hot spot. An online questionnaire was administered at three time points between the first wave of the pandemic in France and the fourth wave. The questionnaire was completed by 1415 to 2224 patients, which queried patients’ demographics, their behavior, and COVID infection patterns. Seventy percent of the patients were female, and 40% had a comorbid condition. More than one-third of the participants had breast cancer, and half were survivors. The rate of infection was 30% during wave 1 and 10% in wave 4; most patients had a mild COVID-19 infection. Twenty-five percent of infected patients during wave 4 did not seek medical advice. At wave 4, 87% of the patients received at least one dose of vaccine. Systematic compliance to shielding measures decreased over time. The short-term pattern of mild COVID changed between wave 1 and wave 4. Twenty-two percent of infected patients experienced persistent signs for more than 6 months with a negative impact on sleep, social behavior, and increased consumption of stress-relieving drugs. Our results showed a high prevalence of long-lasting symptoms in cancer patients with mild COVID-19 infection and inadequate behavior toward the disease and prevention measures among patients.
Collapse
Affiliation(s)
- Nawale Hajjaji
- Medical Oncology department, Oscar Lambret Cancer Center, Lille, France
- Inserm, U1192, Laboratoire Protéomique, Réponse Inflammatoire et Spectrométrie de Masse (PRISM), Univ. Lille, Lille, France
- *Correspondence: Nawale Hajjaji,
| | | | - Sarra Lakhdar
- Medical Oncology department, Oscar Lambret Cancer Center, Lille, France
| | - Stéphanie Bécourt
- Medical Oncology department, Oscar Lambret Cancer Center, Lille, France
| | - Charlotte Bellier
- Medical Oncology department, Oscar Lambret Cancer Center, Lille, France
| | - Emilie Kaczmarek
- Medical Oncology department, Oscar Lambret Cancer Center, Lille, France
| | - Antonin Broyelle
- Medical Oncology department, Oscar Lambret Cancer Center, Lille, France
| | | | - Eric Lartigau
- Radiotherapy department, Oscar Lambret Cancer Center, Lille, France
| |
Collapse
|
3
|
Vanderpool RC, Gaysynsky A, Chou WYS, Tonorezos ES. Using Behavioral Science to Address COVID-19 Vaccine Hesitancy Among Cancer Survivors: Communication Strategies and Research Opportunities. J Behav Med 2022; 46:366-376. [PMID: 35305205 PMCID: PMC8933612 DOI: 10.1007/s10865-022-00304-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2021] [Accepted: 02/22/2022] [Indexed: 11/28/2022]
Abstract
Due to cancer survivors’ increased vulnerability to complications from COVID-19, addressing vaccine hesitancy and improving vaccine uptake among this population is a public health priority. However, several factors may complicate efforts to increase vaccine confidence in this population, including the underrepresentation of cancer patients in COVID-19 vaccine trials and distinct recommendations for vaccine administration and timing for certain subgroups of survivors. Evidence suggests vaccine communication efforts targeting survivors could benefit from strategies that consider factors such as social norms, risk perceptions, and trust. However, additional behavioral research is needed to help the clinical and public health community better understand, and more effectively respond to, drivers of vaccine hesitancy among survivors and ensure optimal protection against COVID-19 for this at-risk population. Knowledge generated by this research could also have an impact beyond the current COVID-19 pandemic by informing future vaccination efforts and communication with cancer survivors more broadly.
Collapse
Affiliation(s)
- Robin C Vanderpool
- Health Communication and Informatics Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 9609 Medical Center Drive, 20850, Rockville, MD, USA.
| | - Anna Gaysynsky
- Health Communication and Informatics Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 9609 Medical Center Drive, 20850, Rockville, MD, USA.,ICF Next, Rockville, MD, USA
| | - Wen-Ying Sylvia Chou
- Health Communication and Informatics Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 9609 Medical Center Drive, 20850, Rockville, MD, USA
| | - Emily S Tonorezos
- Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA
| |
Collapse
|
4
|
Street RL, Finset A. Two years with COVID-19: New - and old - challenges for health communication research. PATIENT EDUCATION AND COUNSELING 2022; 105:261-264. [PMID: 35120714 PMCID: PMC8805952 DOI: 10.1016/j.pec.2022.01.006] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/02/2023]
Affiliation(s)
- Richard L Street
- Department of Communication, Texas A&M University, College Station, TX, United States.
| | | |
Collapse
|
5
|
Dhawan D, Bekalu M, Pinnamaneni R, McCloud R, Viswanath K. COVID-19 News and Misinformation: Do They Matter for Public Health Prevention? JOURNAL OF HEALTH COMMUNICATION 2021; 26:799-808. [PMID: 34865604 DOI: 10.1080/10810730.2021.2010841] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
An infodemic caused by a rampant spread of a mixture of correct and incorrect information in a connected world creates uncertainty about and dismissal of proven public health measures. Two key factors that can influence COVID-19 preventive behaviors are information and self-efficacy. Misinformation (inaccurate or misleading information) can modify people's attitudes and behaviors and deter them from following preventive behaviors. Self-efficacy, on the other hand, has been linked to the likelihood to engaging in preventive behaviors. This cross-sectional study used a nationally representative survey of Americans from 2020 to determine the associations between (1) COVID-19 news sources and COVID-19 misinformation and (2) COVID-19 misinformation and COVID-19 prevention self-efficacy, using multivariable logistic regression. Results indicate that reliance on conservative sources for COVID-19 news is significantly associated with endorsing COVID-19 misinformation. In contrast, reliance on liberal sources, mainstream print, or social media for COVID-19 news are significantly negatively associated with endorsing COVID-19 misinformation. Furthermore, endorsing COVID-19 misinformation is related to low COVID-19 prevention self-efficacy, which, in turn, can modify COVID-19 preventive behaviors. These findings suggest that customizing health messages to debunk misinformation and increase self-efficacy for preventive behaviors can motivate individuals to comply with preventive behaviors and protect themselves from COVID-19.
Collapse
Affiliation(s)
- Dhriti Dhawan
- Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
| | - Mesfin Bekalu
- Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Ramya Pinnamaneni
- Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| | - Rachel McCloud
- Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
| | - K Viswanath
- Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
- Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA, USA
| |
Collapse
|